View in EDS HTML Full Text PDF Full Text

A Phase 3, randomized, non-inferiority study of a heterologous booster dose of SARS CoV-2 recombinant spike protein vaccine in adults.

Saved in:
Bibliographic Details
Title: A Phase 3, randomized, non-inferiority study of a heterologous booster dose of SARS CoV-2 recombinant spike protein vaccine in adults.
Authors: Kulkarni, Prasad S.1 (AUTHOR) drpsk@seruminstitute.com, Gunale, Bhagwat1 (AUTHOR), Kohli, Sunil2 (AUTHOR), Lalwani, Sanjay3 (AUTHOR), Tripathy, Srikanth4 (AUTHOR), Kar, Sonali5 (AUTHOR), Raut, Sidram6 (AUTHOR), Kulkarni, Praveen7 (AUTHOR), Apte, Aditi8 (AUTHOR), Bavdekar, Ashish8 (AUTHOR), Bhalla, Hira Lal9 (AUTHOR), Plested, Joyce S.10 (AUTHOR), Cloney-Clark, Shane10 (AUTHOR), Zhu, MingZhu10 (AUTHOR), Kalkeri, Raj10 (AUTHOR), Pryor, Melinda11 (AUTHOR), Hamilton, Stephanie11 (AUTHOR), Thakar, Madhuri12 (AUTHOR), Sannidhi, Ranga S.13 (AUTHOR), Baranwal, Punjita13 (AUTHOR)
Source: Scientific Reports. 11/20/2023, Vol. 13 Issue 1, p1-14. 14p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20452322
DOI:10.1038/s41598-023-43578-w